Categories Uncategorized

Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Makes Psychedelic Treatment More Accessible with Opening of New Reno Clinic

  • Following the acquisition of KWC back in November 2021, Delic Holdings Corp set out to open additional state-of-the-art ketamine infusion treatment clinics over the course of 18 months
  • The company has just announced the opening of its second clinic in Nevada in a move that will serve both local patients and those in larger California markets without access to affordable in-state providers
  • Delic is still set to open more clinics over the course of the next 18 months in a move that seeks to expand access to reasonably priced treatments for various mental health conditions

In November 2021, Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) announced the completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”). This transaction would bring Delic’s consolidated revenue run rate to $11 million. In addition, and more importantly, it would earn it the title of the largest chain of wellness centers providing ketamine treatments in the United States (https://ibn.fm/AQOU5).

Following the acquisition, Delic set out to open additional state-of-the-art ketamine infusion treatment clinics over 18 months in a move that would expand access to millions of people who can benefit from new medicines and treatments for various mental health conditions. In what marks a significant milestone for the company, it has opened its second clinic in Nevada, bringing the total number of KWC clinics to 13 across nine states (https://ibn.fm/VJXKL).

The new Reno location features a 2,200 square-foot treatment facility, fully equipped to serve both local patients and those in larger California markets who do not have access to affordable in-state providers. Delic is confident that this new location and the others to come over the next 18 months will expand access to reasonably priced treatments for various mental health conditions.

“KWC Reno expands our footprint to serve so many more individuals suffering from treatment-resistant anxiety, depression and PTSD to further combat the country’s on-going mental health crisis,” noted Kevin Nicholson, KWC’s Chief Executive Officer (“CEO”) and Delic’s Chief Operating Officer (“COO”).

“We look forward to providing the most effective and personalized treatments to patients in both Nevada and California,” he added (https://ibn.fm/VJXKL).

This move by Delic complements the company’s overall goal of scaling the impact and reach of treatment. So far, the company’s standing is defined by its umbrella of businesses that form an ecosystem. These include the largest and most accessible network of physical clinics, a licensed lab for R&D and innovation, trusted media, e-commerce platforms, and in-person events that market services directly to patients and consumers.

For more information, visit the company’s website at www.DelicCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage

The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…

4 days ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…

1 week ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…

4 weeks ago

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…

4 weeks ago